Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).

Sci Rep · 2024 · PMC10770310 · PMID 38182630

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

probably not significantno p-value reported

As our cohort was mainly in the early stages of the disease, the differences between FAP stages were probably not significant.

also in 240 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.